Author

A. E. Grigoriadis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Gartland· 1 shared A. J. Caetano· 1 shared A. M. Flanagan· 1 shared A. P. Leite· 1 shared A. Ridley· 1 shared C. Cosstick· 1 shared C. Davies· 1 shared F. Amary· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Gartland

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The RNA binding proteins LARP4A and LARP4B promote sarcoma and carcinoma growth and metastasis

J. C. Coleman, L. Tattersall, V. Yianni, L. Knight, H. Yu, S. Hallett, P. Johnson, A. J. Caetano, C. Cosstick, A. Ridley, A. Gartland, M. R. Conte, A. E. Grigoriadis

This study identifies LARP4A and LARP4B as pro-tumorigenic RNA-binding proteins that promote sarcoma and carcinoma growth and metastasis through cell cycle regulation.

bioRxiv · Apr 11, 2023Cancer Biology

Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone.

L. Cottone, L. Ligammari, H. J. Knowles, H.-M. Lee, S. Henderson, S. Bianco, C. Davies, S. Strauss, F. Amary, A. P. Leite, R. Tirabosco, K. Haendler, J. L. Schultze, J. Herrero, P. ODonnell, , A. M. Flanagan

This study identifies aberrant paracrine signaling between osteoprogenitors and osteoclasts driven by H3.3 mutations as a mechanism underlying giant cell tumor of bone and its response to treatment.

bioRxiv · Dec 27, 2021Cancer Biology